SCHEMBL6255377

SCHEMBL6255377

Cn1c(=O)n(Cc2ccccc2)c(=O)c2c(C(=O)O)csc21

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
ERCC5 P28715 1/20 0.50
FEN1 P39748 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.47
PKM P14618 1/20 0.47
RAB9A P51151 1/20 0.47
NOTUM Q6P988 1/20 0.46
ALDH1A1 P00352 2/20 0.44
LMNA P02545 1/20 0.44
LGMN Q99538 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
ADORA2B P29275 1/20 0.43
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7169149 0.92 MEN1 (0.48) MEN1KMT2AERCC5FEN1SMN1; SMN2
SCHEMBL6471284 0.86 MEN1 (0.46) MEN1KMT2AERCC5FEN1SMN1; SMN2
SCHEMBL6474542 0.84 ADORA2B (0.44) MEN1KMT2AERCC5FEN1SMN1; SMN2
SCHEMBL6470960 0.84 TRPA1 (0.44) MEN1KMT2AERCC5FEN1SMN1; SMN2
SCHEMBL6476633 0.84 ALDH1A1 (0.43) MEN1KMT2AERCC5FEN1SMN1; SMN2
SCHEMBL6472164 0.84 ERCC5 (0.43) MEN1KMT2AERCC5FEN1SMN1; SMN2
SCHEMBL6470623 0.83 ADORA2B (0.42) MEN1KMT2AERCC5FEN1SMN1; SMN2
SCHEMBL6473393 0.83 TSHR (0.47) MEN1KMT2AERCC5FEN1SMN1; SMN2
SCHEMBL7027372 0.83 ERCC5 (0.42) MEN1KMT2AERCC5FEN1SMN1; SMN2
SCHEMBL6465721 0.82 ERCC5 (0.41) MEN1KMT2AERCC5FEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1530467-A2 COMBINATION OF AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 WITH CELECOXIB OR VALDECOXIB Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
EP-1530475-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
WO-2004006931-A2 PHARMACEUTICAL COMPOSTIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed
WO-2004006912-A2 COMBINATION OF AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 WITH CELECOXIB OR VALDECOXIB WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed
EP-1370562-A1 THIENO[2,3-D]PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS Warner-Lambert Company LLC (US) 2003-12-17 EP disclosed
WO-2002064598-A1 THIENO'2,3-D PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-08-22 WO disclosed